2-(4-amino-1-methyl-2-pyrrolecarboxamido)-1,1-dimethoxyethane | 758727-13-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(4-amino-1-methyl-2-pyrrolecarboxamido)-1,1-dimethoxyethane
• 英文别名: 4-amino-N-(2,2-dimethoxyethyl)-1-methylpyrrole-2-carboxamide
• CAS: 758727-13-8
• 化学式: C₁₀H₁₇N₃O₃
• 分子量: 227.263
• InChiKey: YANMHXPSUPJZQG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  78.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(4-amino-1-methyl-2-pyrrolecarboxamido)-1,1-dimethoxyethane 在 二氯乙酸 、 4-二甲氨基吡啶 、 MP-NEt₃⁽¹⁺⁾*BCNH₃^(1-) 、 双(2-氧代-3-恶唑烷基)次磷酰氯 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 N-甲基吡咯烷酮 为溶剂， 反应 3.17h， 生成 N-[5-[[4-[[5-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]phenyl]carbamoyl]-1-methylpyrrol-3-yl]isoquinoline-3-carboxamide
  参考文献：
  名称：

  DNA Binding Ligands with Improved in Vitro and in Vivo Potency against Drug-Resistant Staphylococcus aureus

  摘要：

  Potent in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA) has been difficult to achieve with previously reported DNA binding antibacterials. Herein, we describe an efficient access to a focused library of new analogues yielding compounds with improved activity in a mouse peritonitis model. The most potent molecules (14 and 19) exhibit efficacy against MRSA at ED50 values of similar to1 and similar to5 mg/kg, respectively, and display excellent in vitro activity against vancomycin-resistant S. aureus.

  DOI：

  10.1021/jm049712g
• 作为产物：
  描述：

  1-甲基-4-硝基-1H-吡咯-2-羰酰氯 在 钯 氢气 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 25.0 ℃ 、506.62 kPa 条件下， 反应 2.5h， 生成 2-(4-amino-1-methyl-2-pyrrolecarboxamido)-1,1-dimethoxyethane
  参考文献：
  名称：

  DNA Binding Ligands with Improved in Vitro and in Vivo Potency against Drug-Resistant Staphylococcus aureus

  摘要：

  Potent in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA) has been difficult to achieve with previously reported DNA binding antibacterials. Herein, we describe an efficient access to a focused library of new analogues yielding compounds with improved activity in a mouse peritonitis model. The most potent molecules (14 and 19) exhibit efficacy against MRSA at ED50 values of similar to1 and similar to5 mg/kg, respectively, and display excellent in vitro activity against vancomycin-resistant S. aureus.

  DOI：

  10.1021/jm049712g

文献信息

• DNA Binding Ligands with Improved in Vitro and in Vivo Potency against Drug-Resistant <i>Staphylococcus aureus</i>
  作者：Wenhao Hu、Roland W. Bürli、Jacob A. Kaizerman、Kirk W. Johnson、Matthew I. Gross、Mari Iwamoto、Peter Jones、Denene Lofland、Stacey Difuntorum、Hsiu Chen、Bülent Bozdogan、Peter C. Appelbaum、Heinz E. Moser

  DOI：10.1021/jm049712g

  日期：2004.8.1

  Potent in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA) has been difficult to achieve with previously reported DNA binding antibacterials. Herein, we describe an efficient access to a focused library of new analogues yielding compounds with improved activity in a mouse peritonitis model. The most potent molecules (14 and 19) exhibit efficacy against MRSA at ED50 values of similar to1 and similar to5 mg/kg, respectively, and display excellent in vitro activity against vancomycin-resistant S. aureus.